We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene Mutation Leads to Hypertrophic Cardiomyopathy

By LabMedica International staff writers
Posted on 21 Jun 2017
Print article
Image: The structure of the obscurin protein encoded by the OBSCN gene (Photo courtesy of Wikimedia Commons).
Image: The structure of the obscurin protein encoded by the OBSCN gene (Photo courtesy of Wikimedia Commons).
A team of heart disease researchers explained how a mutation in the gene coding for the obscurin family of proteins leads to the development of an enlarged heart, a condition known as hypertrophic cardiomyopathy.

Obscurins are cytoskeletal proteins with structural and regulatory roles encoded by the OBSCN gene. Mutations in OBSCN are associated with the development of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Specifically, the R4344Q mutation present in immunoglobulin domain 58 (Ig58) of the obscurin protein was the first to be linked with the development of HCM.

In the current study, investigators at the University of Maryland School of Medicine (Baltimore, USA) used a genetically engineered mouse model to assess the effects of the R4344Q mutation in vivo. In the mouse model, mutant obscurins were expressed and incorporated normally into sarcomeres.

A sarcomere is the basic unit of striated muscle tissue. Sarcomeres are composed of long, fibrous proteins as filaments that slide past each other when a muscle contracts or relaxes. Two of the important proteins are myosin, which forms the thick filament, and actin, which forms the thin filament. Myosin has a long, fibrous tail and a globular head, which binds to actin.

In this study, the genetically engineered mice were maintained in three groups: one group experienced no stress, one group experienced moderate stress, and one group experienced significant stress. Results published in the June 7, 2017, online edition of the journal Science Advances revealed that in the mice maintained with little or no stress, the R4344Q mutation resulted in Ca2+ deregulation and spontaneous arrhythmia, whereas in the presence of chronic, pathological stress, it led to cardiac remodeling and dilation that produced hearts that were scarred and ineffective.

At the molecular level, structural analysis revealed that the R4344Q mutation altered the distribution of electrostatic charges over the Ig58 surface of the obscurin protein, thus interfering with its binding capabilities.

"This study gives us new information about the involvement of obscurins in the mechanics of heart disease," said senior author Dr. Aikaterini Kontrogianni-Konstantopoulos, professor of biochemistry and molecular biology at the University of Maryland School of Medicine. "It suggests that people carrying a mutated version of OBSCN may develop heart disease. This work could eventually lead to targeted therapies for people who have OBSCN mutations."

Related Links:
University of Maryland School of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.